Susquehanna International Group, LLP Dynavax Technologies Corp Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$10.73 - $12.58 $792,947 - $929,662	73,900 Added 44.17%	241,200 $2.71 Million
Q1 2024 May 07, 2024	BUY	$11.7 - $14.98 $256,229 - $328,062	21,900 Added 15.06%	167,300 $2.08 Million
Q4 2023 Feb 14, 2024	SELL	$13.09 - $14.98 $404,481 - $462,882	-30,900 Reduced 17.53%	145,400 $2.03 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $346,336 - $410,726	27,400 Added 18.4%	176,300 $2.6 Million
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.17 $485,605 - $649,281	49,300 Added 49.5%	148,900 $1.92 Million
Q1 2023 May 16, 2023	SELL	$9.44 - $11.88 $1.24 Million - $1.56 Million	-131,400 Reduced 56.88%	99,600 $977,000
Q4 2022 Feb 14, 2023	SELL	$10.27 - $13.29 $2.08 Million - $2.69 Million	-202,300 Reduced 46.69%	231,000 $2.46 Million
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $6.28 Million - $11 Million	-632,400 Reduced 59.34%	433,300 $4.52 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $2.13 Million - $3.67 Million	286,400 Added 36.75%	1,065,700 $13.4 Million
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $3.65 Million - $5.4 Million	374,200 Added 92.37%	779,300 $8.45 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $8.99 Million - $14.3 Million	-682,800 Reduced 62.76%	405,100 $5.7 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $4.38 Million - $9.49 Million	478,500 Added 78.52%	1,087,900 $20.9 Million
Q2 2021 Aug 11, 2021	SELL	$7.25 - $10.99 $2.34 Million - $3.55 Million	-322,700 Reduced 34.62%	609,400 $6 Million
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $3.6 Million - $8.82 Million	788,800 Added 550.45%	932,100 $9.16 Million
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $75,719 - $113,680	-20,300 Reduced 12.41%	143,300 $638,000
Q3 2020 Nov 16, 2020	SELL	$4.32 - $11.7 $2.21 Million - $5.99 Million	-511,700 Reduced 75.77%	163,600 $707,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $1.5 Million - $4.63 Million	509,000 Added 306.07%	675,300 $5.99 Million
Q1 2020 May 15, 2020	SELL	$2.27 - $6.2 $994,941 - $2.72 Million	-438,300 Reduced 72.49%	166,300 $587,000
Q4 2019 Feb 14, 2020	SELL	$3.46 - $6.93 $1.07 Million - $2.15 Million	-310,600 Reduced 33.94%	604,600 $3.46 Million
Q3 2019 Nov 14, 2019	BUY	$2.69 - $4.85 $967,324 - $1.74 Million	359,600 Added 64.72%	915,200 $3.27 Million
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $907,025 - $1.96 Million	248,500 Added 80.92%	555,600 $2.22 Million
Q1 2019 May 15, 2019	SELL	$7.08 - $12.09 $41,064 - $70,122	-5,800 Reduced 1.85%	307,100 $2.25 Million
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $622,710 - $1.02 Million	76,500 Added 32.36%	312,900 $2.86 Million
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $899,415 - $1.21 Million	-75,900 Reduced 24.3%	236,400 $2.93 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $1.92 Million - $2.63 Million	126,800 Added 68.36%	312,300 $4.76 Million
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $4.17 Million - $5.67 Million	-284,800 Reduced 60.56%	185,500 $3.68 Million
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $2.56 Million - $3.57 Million	148,100 Added 45.97%	470,300 $8.8 Million
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $4.9 Million - $6.93 Million	322,200	322,200 $6.93 Million

Others Institutions Holding DVAX

# of Institutions

259

Shares Held

132M

Call Options Held

371K

Put Options Held

99.2K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.43B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account